300122 logo

Chongqing Zhifei Biological Products Co., Ltd. Stock Price

SZSE:300122 Community·CN¥31.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

300122 Share Price Performance

CN¥0
-19.49 (-100.00%)
CN¥0
-19.49 (-100.00%)
Price CN¥0

300122 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with mediocre balance sheet.

1 Risk
1 Reward

Chongqing Zhifei Biological Products Co., Ltd. Key Details

CN¥8.8b

Revenue

CN¥21.8b

Cost of Revenue

-CN¥13.0b

Gross Profit

CN¥1.7b

Other Expenses

-CN¥14.8b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-6.18
-148.97%
-168.87%
71.9%
View Full Analysis

About 300122

Founded
2002
Employees
6292
CEO
Lingfeng Jiang
WebsiteView website
www.zhifeishengwu.com

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vaccine. It also provides cold storage, refrigerated vehicles, and cold roll boxes; and customs clearance and registration of imported vaccines. The company was founded in 2002 and is based in Chongqing, China.

Recent 300122 News & Updates

Recent updates

No updates